ArticleFrontiers in neurology

A multicomponent intervention incorporating CYP2C19 genotype-guided therapy and integrated pharmaceutical care reduces hospitalizations and improves adherence in ischemic stroke.

Dan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.